Thanks. Interesting article...with many...many...variables. Has anyone got a model or done a calculation for each of the candidates they have? Appreciate if you can share, with base assumptions, e.g: U$1b p.a revenue for 1st drug, margin 95%, PE multiple, % discount for stage, etc... Thanking you in advance.
Valuing PYC, page-2
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.3¢ | $174.9K | 1.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1219974 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 404496 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |